Reaction profile

The FDA adverse-event record for blood dyscrasia nos

36 FDA reports name blood dyscrasia nos, a lower-volume reaction in the CVM extract (VeDDRA 1058). Plate stamps and neighbourhood peers follow.

#1907 of 2,481
by report volume (all reactions)
36
reports citing this reaction
44.4%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Blood dyscrasia NOS has 36 reports now versus 36 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Blood dyscrasia NOS changes

FDA AER · VeDDRA plate

Code 1058 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 36 reports
  • DEATH-HOT 44.4%
  • LOWER-Q #1907/2481
  • PHOTO-FINISH Abnormal birth weight
  • SPECIES-DOG Dog · 28
  • DRUG-LEAD Carprofen · 9
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abnormal birth weight (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Blood dyscrasia NOS

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abnormal birth weight · near36Adaptor, leaking · near36Blood dyscrasia NOS · this r…36Contact dermatitis · near36Intestinal occlusion · near36Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Blood dyscrasia NOS

Blood dyscrasia NOS: high death-coded share in the FDA AER plate

Signature read: Blood dyscrasia NOS's 44.4% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 36 named reports in the openFDA extract. Death-coded share is upper-third: 16 of 36 reports (44.4% of named reports). Nearest volume peer: Abnormal birth weight (±0 reports). Lead species Dog (28). Lead co-reported drug Carprofen (9).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 28
Cat 5
Horse 2
Cattle 1

Breeds Most Affected

Retriever - Labrador 5
Terrier - Yorkshire 3
Domestic (unspecified) 3
Cat (unknown) 2
Rottweiler 2
Terrier - Bull - American Pit 2
Shepherd Dog - German 1
Great Pyrenees 1
Beagle 1
Terrier - Jack Russell 1

Associated Drugs

Carprofen 9
Cefovecin Sodium 6
Moxidectin 4
Oclacitinib Maleate 4
Trilostane 3
Maropitant 2
Firocoxib 2
Fenbendazole 2
Afoxolaner 2
Meloxicam 2
Tiletamine Hcl, Zolazepam Hcl 2
Maropitant Citrate 2
Isoflurane 2
Intranasal Bordetella Vaccine 2
Microchip 2
Enrofloxacin 2
Melarsomine Dihydrochloride 1
Sulfadimethoxine 1
Cefpodoxime Proxetil 1
Methylprednisolone Acetate 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Blood dyscrasia NOS (#1907 of 2,481 by report volume); death-coded 44.4%. PlainBreed reaction plate · death-coded share stamp 44.4% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →